Oliveira, Liliana http://orcid.org/0000-0001-5222-7600
Silva, M. Carolina http://orcid.org/0009-0008-1516-5250
Gomes, Ana P.
Santos, Rita F.
Cardoso, Marcos S. http://orcid.org/0000-0003-0150-7359
Nóvoa, Ana http://orcid.org/0000-0002-5668-5630
Luche, Hervé http://orcid.org/0000-0003-4309-8338
Cavadas, Bruno
Amorim, Irina http://orcid.org/0000-0002-2305-1631
Gärtner, Fátima
Malissen, Bernard http://orcid.org/0000-0003-1340-9342
Mallo, Moisés http://orcid.org/0000-0002-9744-0912
Carmo, Alexandre M. http://orcid.org/0000-0002-2508-9799
Article History
Received: 17 February 2023
Accepted: 29 April 2024
First Online: 15 May 2024
Competing interests
: L.O. and A.M.C. are inventors on the patent application “Recombinant Human CD5L protein, active fragments or peptides derived thereof and pharmaceutical composition comprising the recombinant human CD5L protein, active fragments or peptides derived thereof for the treatment of acute infectious diseases, inflammatory diseases and sepsis”, applicants, IBMC (Instituto de Biologia Molecular e Celular) and INVIGATE GmbH, WO2023/146425, published in 03.08.2023. The remaining authors declare no competing interests.